Henoch-Schönlein purpura associated with acetaminophen and codeine

Clinical Nephrology

Volumn 66, Issue 2, 2006, Pages 131-134

  Santoro, D ^a   Stella, M ^b   Castellino, S ^a  

^a San Vincenzo Hospital   (Italy)

^b VILLA SOFIA CERVELLO HOSPITAL   (Italy)

Author keywords

Drug reaction; Henoch Sch nlein purpura; Paracetamol; Renal disease

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; CODEINE; COEFFERALGAN; COMPLEMENT; CREATININE; CYCLOPHOSPHAMIDE; ENALAPRIL; IMMUNOGLOBULIN A; KETOROLAC; LOSARTAN; MEPREDNISONE; METOCLOPRAMIDE; PARACETAMOL; PREDNISONE; RANITIDINE; SPIRAMYCIN; STREPTOKINASE; THALIDOMIDE; TROMETAMOL; VANCOMYCIN;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; AGED; ANAPHYLACTOID PURPURA; ARTHRALGIA; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CERVICAL SPONDYLOSIS; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG ERUPTION; DRUG UTILIZATION; DRUG WITHDRAWAL; FEVER; HEMATURIA; HUMAN; HYPOCOMPLEMENTEMIA; IMMUNOGLOBULIN A NEPHROPATHY; MALE; MEDICAL ASSESSMENT; MEDLINE; PALPATION; PATIENT MONITORING; PURPURA; RELAPSE; THROMBOCYTOPENIA;

EID: 33747108761     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp66131     Document Type: Article

References (26)

1. Blanco R, Martinez-Taboada VM, Rodriguez-Valverde V, Garcia-Fuentes M, Gonzalez-Gay MA. Henoch-Schoenlein purpura in adulthood and childhood: two different expressions of the same syndrome. Arthritis Rheum. 1997; 40: 859-864.
2. Borras-Blasco J, Enriquez R, Amoros F, Cabezuelo JB, Navarro-Ruiz A, Perez M, Fernandez J. Henoch-Schoenlein purpura associated with clarithromycin. Case report and review of literature. Int J Clin Pharmacol Ther. 2003; 41: 213-216.
3. Borras-Blasco J, Girona E, Navarro-Ruiz A, Matarredona J, Gimenez ME, Gutierrez A, Enriquez R, Martinez A. Acenocoumarol-induced Henoch-Schonlein purpura. Ann Pharmacother. 2004; 38: 261-264.
4. Bosch X. Henoch-Schonlein purpura induced by losartan therapy. Arch Intern Med. 1998; 158: 191-192.
5. Choi SJ, Park SK, Uhm WS, Hong DS, Park HS, Park YL, Kwon KW. A case of refractory Henoch-Schonlein purpura treated with thalidomide. Korean J Intern Med. 2002; 17: 270-273.
6. Cameron JS. Henoch-Schoenlein purpura: clinical presentation. Contrib Nephrol. 1984; 40: 246-249.
7. Coppo R, Amore A, Gianoglio B. Clinical features of Henoch-Schoenlein purpura. Italian Group of Renal Immunopathology. Ann Med Interne (Paris). 1999; 150: 143-150.
8. Escudero A, Lucas E, Vidal JB, Sanchez-Guerrero I, Martinez A, Illan F, Ramos J. Drug-related Henoch-Schonlein Purpura. Allergol Immunopathol. 1996; 24: 22-24.
9. Gamboa F, Rivera JM, Gomez Mateos JM, Gomez-Gras E. Ciprofloxacin-induced Henoch-Schonlein purpura. Ann Pharmacother. 1995; 29: 84.
10. Goad JA. Reversible nonthrombocytopenic palpable purpura associated with metoclopramide. Ann Pharmacother. 1999; 33: 35-37.
11. Goldberg EI, Shoji T, Sapadin AN. Henoch-Schonlein purpura induced by clarithromycin. Int J Dermatol. 1999; 38: 706-708.
12. Goncalves R, Cortez Pinto H, Serejo F, Ramalho F. Adult Schonlein-Henoch purpura after enalapril. J Intern Med. 1998; 244: 356-357.
13. Habib R, Niaudet P, Levy M. Schoenlein-Henoch purpura nephritis and IgA nephropathy. In: Tisher CC, Brenner BM (eds). Renal pathology with clinical and functional correlations. Philadelphia: Lippincott; 1993. pp. 472-523.
14. Michail S, Vaiopoulos G, Nakopoulou L, Revenas C, Aroni K, Karam P, Stathakis C, Thosios T. Henoch-Schoenlein purpura and acute interstitial nephritis after intravenous vancomycin administration in a patient with a staphylococcal infection. Scand J Rheumatol. 1998; 27: 233-235.
15. Michel BA, Hunder GG, Bloch DA, Calabrese LH. Hypersensitivity vasculitis and of Henoch-Schoenlein purpura: a comparison between 2 disorders. J Rheumatol. 1992; 19: 721-728.
16. Miura M, Nomoto Y, Sakai H, Yamamoto O. An aged patient with Henoch-Schoenlein purpura nephritis: a case report and review of the literature. Intern Med. 1992; 31: 232-238.
17. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30: 239-245.
18. Nielsen HE. Epidemiology of Schoenlein-Henoch purpura. Acta Paediatr Scand. 1988; 77: 125-131.
19. Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D. Henoch-Schoenlein purpura in adults: outcome and prognostic factors. J Am Soc Nephrol. 2002; 13: 1271-1278.
20. Pons R, Escutia B. Ciprofloxacin-induced vasculitis with cutaneous and renal involvement Nefrologia. 2001; 21: 209-212.
21. Prajapati C, Casson IF. Henoch-Schonlein purpura associated with ranitidine. Int J Clin Pract. 1997; 51: 251.
22. Richards AJ, Lindley DC. Henoch-Schoenlein purpura associated with co-dydramol. Br J Rheumatol. 1987; 6: 65.
23. Sola Alberich R, Jammoul A, Masana L. Henoch-Schonlein purpura associated with acetylsalicylic acid. Ann Intern Med. 1997; 126: 665.
24. Valera Prieto I, Calvo Catala J, Hortelano Martinez E, Abril L de Medrano V, Glez-Cruz Cervellera MI, Herrera Ballester A, Orti E. Schoenlein-Henoch purpura associated with spiramycin and with important digestive manifestations] Rev Esp Enferm Dig. 1994; 85: 47-549.
25. de Vega T, Blanco S, Lopez C, Pascual E, Sanchez M, Zamarron A. Clarithromycin-induced leukocytoclastic vasculitis. Eur J Clin Microbiol Infect Dis. 1993; 12: 563.
26. Zilliox AP, Domoto DT, Hutcheson PS, Tsai CC, Slavin RG. Henoch-Schoenlein purpura due to streptokinase. J Clin Immunol. 1993; 13: 415-23.